Pharmaceutical market access

A product can be ready. A market may not be.

Connecting product rights and regulatory pathways with commercial evidence and qualified partners.

A clear sequence

Six questions before launch.

Regulatory approval, commercial market access and physical supply are distinct decisions.

  1. 01

    Product identity

    What is the formulation, dossier, presentation, rights holder and current authorisation status?

  2. 02

    Country and route

    Which local registration, import, wholesale, device or supplement regime applies?

  3. 03

    Accountability

    Who is responsible for regulatory ownership, quality, importation and contractual duties?

  4. 04

    Commercial viability

    What are the relevant procurement channels, reimbursement conditions, demand and economics?

  5. 05

    Supply integrity

    Which sources, quality agreements, GDP controls, handling records and continuity plans are required?

  6. 06

    Release readiness

    Have the applicable authorisations, evidence and customer eligibility been independently verified?

Commercial applications

From the dossier to the decision.

Opportunities may involve generics, oncology, specialist medicines, OTC, PLPI strategy, medical devices or food supplements. Each category requires its own regulatory and commercial assessment.

Start with a product and a target market.

Share the product, target geography, organisation role and relevant permissions so the next decision is grounded in evidence.